This '90s shoe trend was all the rage at New York Fashion Week
Teva found liable for fueling opioid addiction in New York | Mint
Teva Pharmaceuticals Takes Hit in New York Opioid Case
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Drug Manufacturer Teva to Pay $523M to New York in Opioid Settlement
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Drugmaker Teva Misled Court to Dodge Opioid Trial, New York State Claims - Bloomberg
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
New York jury holds drug firm Teva liable in opioid crisis
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
In landmark ruling, New York jury finds Teva Pharmaceuticals liable for state's drug epidemic - CBS News
In opioid case, NY wants to probe Teva's control of Teva USA
Teva to pay New York $500M for role in opioid crisis - POLITICO
New York jury holds Teva Pharmaceuticals liable in opioid crisis
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva's picked an address in Parsippany, New Jersey, and the dirt's about to fly | Fierce Pharma
New York could get $524M under opioid settlements with Teva - ABC News
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva lied about opioid role, New York says
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Opioid maker Teva to pay $523M settlement over its role in New York epidemic, AG James says - Newsday
Wow, Tevas Got Cute - The New York Times
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
